Pharmacokinetics and Pharmacodynamics Comparison Study Between Two Pegfilgrastim Formulations
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Pegfilgrastim
Related studies linked through entity extraction aliases.
Metformin in Combination With Standard Induction Therapy for Large B-cell Lymphoma (DLBCL)
- Status
- TERMINATED
- Phase
- PHASE2
Chemotherapy Before Surgery in Treating Patients With High Grade Upper Urinary Tract Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Loratadine for Pegfilgrastim Induced Bone Pain in Patients With Aggressive Lymphoma
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Comparison of the Pharmacokinetic and Pharmacodynamic Biosimilarity of CHS-1701 (Coherus Pegfilgrastim) With Neulasta® (Pegfilgrastim)
- Status
- COMPLETED
- Phase
- PHASE1
Mitomycin C in Patients With Incurable p16 Positive Oropharyngeal and p16 Negative Head and Neck Squamous Cell Carcinoma (HNSCC) Resistant to Standard Therapies
- Status
- COMPLETED
- Phase
- PHASE2
Pegfilgrastim on Day +3 Compared to Day +1 After Salvage Chemotherapy for Patients With Refractory or Relapsed Aggressive Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE3
Phase I Study of Romidepsin, Gemcitabine, Oxaliplatin, and Dexamethasone in Patients With Relapsed/Refractory Aggressive Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
Dose-Dense Induction/Neoadjuvant Chemotherapy in Locally Advanced Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Carfilzomib, Rituximab, and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A comparatiVe Study on Efficacy and Safety of Lipegfilgrastim in Comparison to Pegfilgrastim in Elderly Patients With Aggressive B Cell Non-HOdgkin Lymphomas at hIgh Risk for R-CHOP-21-inDuced Neutropenia
- Status
- COMPLETED
- Phase
- PHASE3
Study of Vorinostat in Combination With Gemcitabine and Docetaxel in Advanced Sarcoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
High Dose Therapy and Autologous Stem Cell Transplantation Followed by Infusion of Chimeric Antigen Receptor (CAR) Modified T-Cells Directed Against CD19+ B-Cells for Relapsed and Refractory Aggressive B Cell Non-Hodgkin Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Paclitaxel With Trastuzumab and Lapatinib in HER2-Positive Early Stage Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase 2 Study of SPI-2012 or Pegfilgrastim for the Management of Neutropenia in Participants With Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
NOLAN: Naproxen or Loratadine and Neulasta
- Status
- COMPLETED
- Phase
- PHASE2
Pegfilgrastim and Rituximab in Treating Patients With Untreated, Relapsed, or Refractory Follicular Lymphoma, Small Lymphocytic Lymphoma, or Marginal Zone Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Tivantinib and Topotecan Hydrochloride in Treating Patients With Advanced or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Gemcitabine Hydrochloride and Cisplatin or High-Dose Methotrexate, Vinblastine, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Urothelial Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2